Product Information

SIMVASTATIN 5 MG TABLET is a generic product labeled by Quallent Pharmaceuticals Health LLC, priced at $0.0314 per EA under NDC 82009001210. Its NADAC has been published 167 times since Jun 14, 2023.

FDA first approved this application on Nov 25, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

SIMVASTATIN 5 MG TABLET

Simvastatin
$0.0314per EA

Strength

5 mg/1

NDC

82009001210

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

SIMVASTATIN

Approval Type

Generic (ANDA)

FDA Application

ANDA200895

FDA Approved

11/25/2014

TE Code

AB

On Market Since

5/26/2022

Pharmacological Classes

HMG-CoA Reductase Inhibitor
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Price Statistics

The NADAC for SIMVASTATIN 5 MG TABLET has been published 167 times since Jun 14, 2023, and over the history we have for it it has declined 19.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0314 per EA
All-time high$0.0436 (Feb 14, 2024)
All-time low$0.0287 (Apr 22, 2026)
52-week high$0.0353
52-week low$0.0287
Median price$0.0353
Average price$0.0353
Largest weekly change-22.0% (Apr 17, 2024)
Weeks tracked167
Tracking sinceJun 14, 2023

Price History

1W

+7.6%

1M

+7.6%

3M

+7.3%

6M

+9.1%

1Y

-10.8%

3Y

-23.0%

5Y

N/A

All

-19.1%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of SIMVASTATIN 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for SIMVASTATIN 5 MG TABLET, manufactured by Quallent Pharmaceuticals Health LLC, is $0.0314 per EA (NDC 82009001210), effective Aug 19, 2026.

How has the price of SIMVASTATIN 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for SIMVASTATIN 5 MG TABLET has declined 19.1%. It has been tracked across 167 weekly CMS publications since Jun 14, 2023.

What are the highest and lowest recorded NADAC prices for SIMVASTATIN 5 MG TABLET?

Since Jun 14, 2023, the NADAC for SIMVASTATIN 5 MG TABLET has ranged from a low of $0.0287 (Apr 22, 2026) to a high of $0.0436 (Feb 14, 2024), with a median of $0.0353 per EA.

Are there cheaper alternatives to SIMVASTATIN 5 MG TABLET?

Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SIMVASTATIN 5 MG TABLET, is $0.0288 per EA — about 8% below SIMVASTATIN 5 MG TABLET.

Who manufactures SIMVASTATIN 5 MG TABLET?

SIMVASTATIN 5 MG TABLET (NDC 82009001210) is labeled by Quallent Pharmaceuticals Health LLC, and CMS classifies it as a generic product.